Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Progyny Inc PGNY

Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.4 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.


NDAQ:PGNY - Post by User

<< Previous
Bullboard Posts
Next >>
Post by whytestockson Aug 07, 2024 6:00pm
22 Views
Post# 36168438

Reduce Recommendation Issued On PGNY By Canaccord Genuity

Reduce Recommendation Issued On PGNY By Canaccord Genuity
JUST IN: $PGNY Reduce Recommendation Issued On PGNY By Canaccord Genuity2024-08-07 05:15:04 ET Canaccord Genuity analyst issues REDUCE recommendation for PGNY on August 7, 2024 02:19AM ET. PGNY was trading at $25.74 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 4 - Buy reco...PGNY - Reduce Recommendation Issued On PGNY By Canaccord Genuity

<< Previous
Bullboard Posts
Next >>